- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02165410
MRI Study of Cerebral Blood Flow in Development Disorders in Children (IRM-Aut)
Study Overview
Status
Conditions
Detailed Description
Anatomical and functional abnormalities have been identified in the superior temporal sulcus (STS) in autism by brain imaging modalities, including positron emission tomography (PET), functional MRI and diffusion MRI. These results suggest that brain imaging abnormalities within the STS could be the first step in the cascade of neuronal abnormalities found in autism.
STS is known as a key area for social cognition and is involved in various stages of social interaction, from visual and auditory perception (perception of eyes, facial and body movements, and perception of human voice) to the more complex process of social cognition (theory of mind, understanding emotions and mentalizing) The anatomical and functional abnormalities within the STS described in autism could account for the social difficulties experienced by persons with autism, both clinically observed and objectified by studies on visual social perception.
The individual detection results found in PET, that is to say a reduction of rCBF in the superior temporal sulcus (STS), could be reproduced with ASL and used to predict the diagnosis of autism in children with the same level of sensitivity and specificity as with PET. The individual detection of decreased rCBF in the STS could be a useful biomarker in autism using MRI, a method more accessible and much less invasive than PET. A MRI biomarker in autism could allow individual analysis, as well as contribute to early diagnosis and objective evaluation of the efficacy of new therapeutic strategies.
The rCBF data measured by MRI-ASL will also be correlated with both clinical (Autism Diagnostic Interview - ADI-R) and behavioral data of the social perception measured by the eye-tracking method. In addition, we will study the impact of these temporal anomalies on brain connectivity MRI method of diffusion tensor. We will also describe the abnormalities present in the very early development of autism.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Paris, France, 75743
- Hôpital Necker-Enfants Malades Service de Radiologie Pédiatrique
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
Patient diagnosed autist or suspected autist : males and females with the diagnosis of autism based on the following criteria:
- 5 years ≤ age < 18 years,
- demand for MRI in the etiologic assessment (suspected autism) or MRI control in the treatment (diagnosed with autism)
- obtaining written consent from parents or legal guardians of patients.
Patients diagnosed with mental retardation or suspected with mental retardation : males and females with the diagnosis of mental retardation using the following criteria:
- 5 years ≤ age < 18 years,
- demand for MRI in the etiologic assessment (suspected mental retardation) or MRI control in the treatment (diagnosed with mental retardation)
- obtaining written consent from parents or legal guardians of patients.
Healthy control subjects: males and females:
- 5 years ≤ age < 18 years
- no known neurological or psychiatric disorder obtaining written consent with parents or legal guardians of volunteers.
Very young patients suspected of autism: male and female with suspected autism
- 18 months ≤ age <5 years
- demand of MRI in the etiologic assessment
- obtaining written consent from parents or legal guardians.
Very young patients suspected of mental retardation : male and female with suspected mental retardation
- 18 months ≤ age <5 years
- demand of MRI in the etiologic assessment
- obtaining written consent from parents or legal guardians.
All subjects must be registered with the social security.
Exclusion Criteria:
For all subjects:
- Indication against performing MRI (pacemaker, an implanted metal foreign body, claustrophobia),
- Inability of healthy volunteers to remain still during the MRI examination.
Healthy control subjects: males and females:
- aged between 5 years and 18 years
- no known neurological or psychiatric disorder
- obtaining written consent with parents or legal guardians of volunteers.
All subjects must be registered with the social security.
Exclusion Criteria:
For all subjects:
- Indication against performing MRI (pacemaker, an implanted metal foreign body, claustrophobia),
- Inability of healthy volunteers to remain still during the MRI examination.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Eye tracking and RMI
|
ASL MRI is a non-invasive technique without injection to measure rCBF at rest marking the intravascular water molecules and use it as an endogenous tracer.
Premedication, if required, will concern autistic and mentally retarded subjects only.
Diffusion MRI enables the mapping of the diffusion process of water molecules, which allows visualizing anatomical connections between different parts of the brain, noninvasively and on an individual basis.
The sequence is acquired following clinical MRI sequences, while the child is still inside the MRI machine, with no further intervention applied.
This sequence is based on the synchronization of fluctuations in the blood-oxygen level dependent (BOLD) signal of different brain regions that work as a network.
Therefore this sequence allows for the establishing of maps of funcitonal connectivity.
Eye tracking is a non-invasive method that allows objectifying gaze parameters during presentation of stimuli on a computer screen.
Children will be presented with a series of social and no social stimuli and are required to watch it, with no further intervention applied.
Children will be asked to perform certain tasks, adapted for their age.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
CBF
Time Frame: at day 0
|
ASL is an MRI technique to measure CBF at rest by labeling arterial intravascular water and use as an endogenous tracer.
This sequence is performed without injection of contrast or injection of radioactivity
|
at day 0
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
anatomical connectivity
Time Frame: at Day 0
|
Diffusion tensor MRI (DTI) enables the mapping of the diffusion process of water molecules, which allows visualizing anatomical connections between different parts of the brain, noninvasively and on an individual basis.
|
at Day 0
|
|
eye-tracking method
Time Frame: at day 0
|
Eye tracking is a non-invasive method that allows objectifying gaze parameters during presentation of stimuli on a computer screen.
|
at day 0
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Nathalie BODDAERT, MD, PhD, Assistance Publique Hopitaux de Paris
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimated)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Autism Spectrum Disorder
- Neurologic Manifestations
- Nervous System Diseases
- Mental Disorders
- Neurobehavioral Manifestations
- Neurodevelopmental Disorders
- Child Development Disorders, Pervasive
- Pathological Conditions, Signs and Symptoms
- Signs and Symptoms
- Autistic Disorder
- Intellectual Disability
- Investigative Techniques
- Diagnostic Techniques and Procedures
- Diagnosis
- Tomography
- Diagnostic Imaging
- Diagnostic Techniques, Neurological
- Neuroimaging
- Magnetic Resonance Imaging
- Diffusion Magnetic Resonance Imaging
- Diffusion Tensor Imaging
Other Study ID Numbers
- P120204
- 2012-A01695-38 (Other Identifier: ANSM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Autism
-
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...Istituto Clinico HumanitasRecruitingAutism | Autism Spectrum Disorder (ASD) | Autism DisorderItaly
-
Istituto per la Ricerca e l'Innovazione BiomedicaRecruitingAutism | Autism DisorderItaly
-
University of NottinghamUniversity Hospitals of Derby and Burton NHS Foundation Trust; Lincolnshire...Not yet recruitingAutism Spectrum Disorder | Autism | Parent | Autism Disorder | Autism in Children | Parent Stress | Parent Mental Health | Autism Disorders and Maternal Stress | Parent SupportUnited Kingdom
-
Boston Children's HospitalRecruitingAutism Spectrum Disorder | Autism | Autism DisorderUnited States
-
Greater Atlanta Integrative PediatricsRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
The Children's Hospital of Zhejiang University...Not yet recruitingAutism | Autism Spectrum Disorder (ASD)China
-
Poznan University of Physical EducationCompletedAutism | Autism Spectrum Disorder (ASD)Poland
-
Adia Med of Winter Park LLCRecruitingAutism Spectrum Disorder | Autism | ASD | Autism Spectrum Disorder (ASD)United States
-
Stanford UniversityJohn and Marcia Goldman FoundationNot yet recruitingAutism | Autism Spectrum Disorder (ASD)United States
-
Father Flanagan's Boys' HomeNational Institute on Deafness and Other Communication Disorders (NIDCD)Not yet recruitingAutism Spectrum Disorder | Autism | Autism, Susceptibility to, 6United States
Clinical Trials on ASL-MRI
-
University of NottinghamUnknownReversible Cerebral Vasoconstriction SyndromeUnited Kingdom
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)TerminatedRenal Cell CarcinomaUnited States
-
Mayo ClinicCompleted
-
University of Texas Southwestern Medical CenterNational Cancer Institute (NCI)Completed
-
Assistance Publique - Hôpitaux de ParisRecruiting
-
Asan Medical CenterRecruitingBrain Metastases | RadiosurgeryKorea, Republic of
-
University of NottinghamNot yet recruitingKidney Diseases | Ultrasonography | Kidney Injury, Acute | Perfusion ImagingUnited Kingdom
-
Beth Israel Deaconess Medical CenterNovartis; Pfizer; Dana-Farber Cancer Institute; Brigham and Women's HospitalCompletedRenal Cell CarcinomaUnited States
-
Yale UniversityCompletedSmall Vessel Disease of Diabetes MellitusUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI); Rutgers Cancer Institute of New JerseyCompletedStage III Renal Cell Cancer | Stage IV Renal Cell Cancer | Stage I Renal Cell Cancer | Stage II Renal Cell CancerUnited States